Comprehensive Analysis of Epidermal Growth Factor Receptor Gene Status in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive Analysis of Epidermal Growth Factor Receptor Gene Status in Lung Adenocarcinoma

Published:2011-06 Issue:6 Volume:6 Page:1016-1021
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Li Chenguang,Sun Yihua,Fang Zhaoyuan,Han Xiangkun,Fang Rong,Zhang Yang,Pan Yunjian,Zhang Wenjing,Ren Yan,Ji Hongbin,Chen Haiquan

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary;Sant;Ann Oncol,2003

4. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J Clin Oncol,2003

5. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer;Pérez-Soler;J Clin Oncol,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 8-Br-cGMP suppresses tumor progression through EGFR/PLC γ1 pathway in epithelial ovarian cancer;Molecular Biology Reports;2024-01-18

2. Association between epidermal growth factor receptor mutation status, clinicopathological characteristics and TTF-1 expression in lung adenocarcinoma: A single center study;Srpski arhiv za celokupno lekarstvo;2021

3. Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population;Journal of Thoracic Oncology;2019-11

4. A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients;Indian Journal of Cancer;2017

5. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers;Lung Cancer;2016-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3